LILA BIO
Live / Applied — Extension of time to oppose received (as of 08 Jan 2026)
What this means for you
Not registered yet, but its 06 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98889088
- Mark type
- Stylized text
- Filed
- 06 Dec 2024
- Published for opposition
- 09 Dec 2025
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating cancer, infectious diseases, inflammation, fibrosis, hypertension, cardiovascular disease, chronic obstructive pulmonary disease, obesity, and musculoskeletal diseases; Pharmaceutical peptide and protein compositions for treating cancer, infectious diseases, inflammation, fibrosis, hypertension, cardiovascular disease, chronic obstructive pulmonary disease, obesity, and musculoskeletal diseases
Owner
- Lila Biologics, Inc., Seattle, WA, US
- Lila Biologics, Inc., Seattle, WA, US
Prosecution history
- 08 Jan 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Aug 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 13 Aug 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 May 2025 — NON-FINAL ACTION E-MAILED
- 31 May 2025 — NON-FINAL ACTION WRITTEN
- 27 May 2025 — ASSIGNED TO EXAMINER
- 23 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED